Volume 76, Issue 6, Pages (September 2009)

Slides:



Advertisements
Similar presentations
Implementing KDOQI CKD Definition and Staging Guidelines in Southern California Kaiser Permanente  Mark Rutkowski, MD, Wendy Mann, PharmD, Stephen Derose,
Advertisements

Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury  Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian,
Improved prognosis of diabetic nephropathy in type 1 diabetes
Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury  Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian,
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease  Kevin E. Chan, Ravi I. Thadhani,
Volume 83, Issue 3, Pages (March 2013)
Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline  Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,
Development of Reduced Kidney Function in Rheumatoid Arthritis
Volume 92, Issue 1, Pages (July 2017)
Volume 79, Issue 12, Pages (June 2011)
Volume 92, Issue 2, Pages (August 2017)
Intermediate and Long-term Outcomes of Survivors of Acute Kidney Injury Episodes: A Large Population-Based Cohort Study  Simon Sawhney, MBChB, Angharad.
Prehypertension and chronic kidney disease: the ox or the plow?
The urinary metabolome of chronic kidney disease
Volume 80, Issue 1, Pages (July 2011)
John P. Middleton, Patrick H. Pun  Kidney International 
Volume 77, Pages S9-S16 (March 2010)
Susumu Takahashi, Kazuyoshi Okada, Mitsuru Yanai  Kidney International 
Volume 87, Issue 6, Pages (June 2015)
Volume 78, Issue 8, Pages (October 2010)
Volume 86, Issue 4, Pages (October 2014)
Your Kidneys May Outlive You
Volume 78, Issue 12, Pages (December 2010)
Volume 79, Issue 12, Pages (June 2011)
Volume 75, Issue 10, Pages (May 2009)
End-stage renal disease in living kidney donors
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
Anemia as a risk factor for chronic kidney disease
Comorbidity and confounding in end-stage renal disease
Volume 82, Issue 3, Pages (August 2012)
Volume 70, Issue 11, Pages (December 2006)
Manjula Kurella Tamura, Kristine Yaffe  Kidney International 
Volume 88, Issue 5, Pages (November 2015)
Stephen P. McDonald  Kidney International Supplements 
Volume 85, Issue 6, Pages (June 2014)
Volume 75, Issue 1, Pages (January 2009)
U-shaped effect of eGFR and mortality
Volume 76, Issue 10, Pages (November 2009)
Volume 76, Issue 6, Pages (September 2009)
Volume 83, Issue 4, Pages (April 2013)
Volume 70, Issue 12, Pages (December 2006)
Aggressive blood pressure reduction and renin–angiotensin system blockade in chronic kidney disease: time for re-evaluation?  Pantelis A. Sarafidis, Luis.
Volume 81, Issue 6, Pages (March 2012)
Volume 76, Issue 3, Pages (August 2009)
Elevated risk of stroke among patients with end-stage renal disease
Methods for guideline development
Volume 76, Issue 8, Pages (October 2009)
Volume 73, Issue 7, Pages (April 2008)
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Improved prognosis of diabetic nephropathy in type 1 diabetes
Volume 86, Issue 3, Pages (September 2014)
Volume 85, Issue 5, Pages (May 2014)
Volume 80, Issue 3, Pages (August 2011)
Prehypertension: is it relevant for nephrologists?
Volume 77, Issue 12, Pages (June 2010)
Volume 81, Issue 7, Pages (April 2012)
Blood lead and chronic kidney disease in the general United States population: Results from NHANES III  Paul Muntner, Jiang He, Suma Vupputuri, Josef.
Volume 83, Issue 3, Pages (March 2013)
Volume 80, Issue 10, Pages (November 2011)
Volume 83, Issue 3, Pages (March 2013)
Volume 87, Issue 3, Pages (March 2015)
Volume 75, Issue 7, Pages (April 2009)
Ann M. O'Hare, MA, MD  American Journal of Kidney Diseases 
Adiponectin: good, bad, or just plain ugly?
A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan  Yi-Chun.
Volume 78, Issue 5, Pages (September 2010)
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Fistula and Survival Outcomes after Fistula Creation among Predialysis Chronic Kidney Disease Stage 5 Patients Miyamoto et al. Am J Nephrol 2017;45:  
Volume 86, Issue 2, Pages (August 2014)
Presentation transcript:

Volume 76, Issue 6, Pages 629-637 (September 2009) Incidence of end-stage renal disease and death among insured African Americans with chronic kidney disease  Stephen F. Derose, Mark P. Rutkowski, Nathan W. Levin, In-Lu A. Liu, Jiaxiao M. Shi, Steven J. Jacobsen, Peter W. Crooks  Kidney International  Volume 76, Issue 6, Pages 629-637 (September 2009) DOI: 10.1038/ki.2009.209 Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 1 Flow diagram of study cohort assembly. Kidney International 2009 76, 629-637DOI: (10.1038/ki.2009.209) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 2 Cumulative incidence of ESRD and death before ESRD in Blacks and non-Blacks from a study entry eGFR of 15 to <29, 30 to <45, and 45 to <60ml/min per 1.73m2 (raw data). Starting population sizes are given in Table 2. P-values for differences are indicated for each pair of curves (K-sample test for ESRD and death before ESRD; log-rank test for the combined outcome). Solid lines: Blacks. Dashed lines: non-Blacks. eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease. Kidney International 2009 76, 629-637DOI: (10.1038/ki.2009.209) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 3 Risk of ESRD (left) and risk of death before ESRD (right) in Blacks vs non-Blacks by study entry age and eGFR (ml/min per 1.73m2). On the basis of the competing-risk regression models with interaction terms, as shown in Table 4. Solid lines: entry eGFR 60ml/min per 1.73m2. Long dashed lines: entry eGFR 45ml/min per 1.73m2. Dashed lines: entry eGFR 30ml/min per 1.73m2. Dotted lines: entry eGFR 15ml/min per 1.73m2. eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease. Kidney International 2009 76, 629-637DOI: (10.1038/ki.2009.209) Copyright © 2009 International Society of Nephrology Terms and Conditions